Amendment No. 1 to the Master Laboratory Services Agreement Sample Contracts

AMENDMENT NO. 1

Amendment No. 1 to the Master Laboratory Services Agreement • September 25th, 2026 • Chemomab Therapeutics Ltd. • Pharmaceutical preparations

• Contract Type
  Amendment No. 1 to the Master Laboratory Services Agreement
• Filed
  September 25th, 2026
• Company
  Chemomab Therapeutics Ltd.
• Industry
  Pharmaceutical preparations

This Amendment No. 1 to the Master Laboratory Services Agreement (the “Amendment”) by and between Scipher Medicine Corporation (“Company”) and Ambry Genetics Corporation (“Ambry”) is effective as of September 13, 2023 (the “Amendment Effective Date”). Terms used but not defined in this Amendment will have the meanings assigned to them in the Agreement.